9 Background: Current imaging modalities are suboptimal for the initial staging of men at risk
of harboring occult metastatic prostate cancer (PCa). PSMA-based imaging is considered …

32 Background: Conventional imaging and bone scintigraphy are suboptimal modalities for
identifying PCa. PSMA-based imaging is highly promising for PCa detection. 18F-DCFPyL is …

Purpose Prostate-specific membrane antigen (PSMA) PET/CT shows better diagnostic
performance for detection of lymph node and bone metastases as compared to conventional …

586 Objectives: Prostate-specific membrane antigen (PSMA) is a transmembrane protein
that is overexpressed by prostate cancer (PCa) cells. PSMA-based imaging is considered …

Purpose Current standard of care conventional imaging modalities (CIM) such as X-ray
computed tomography (CT) and bone scan can be limited for detection of metastatic prostate …

Prostate cancer is the second most common cancer in men worldwide.[18 F] FDG PET/CT
imaging, a well-known and effective technique for detecting malignancies, has not been …

We previously demonstrated the ability to detect metastatic prostate cancer using N-[N-[(S)-
1, 3-dicarboxypropyl] carbamoyl]-4-18F-fluorobenzyl-l-cysteine (18F-DCFBC), a low …

OBJECTIVE. The purpose of this study was to assess the utility of PET with (2 S)-2-[[(1 S)-1-
carboxy-5-[(6-(18F) fluoranylpyridine-3-carbonyl) amino] pentyl] carbamoylamino] …

TPS5092 Background: Accurate localization of sites of disease is essential for delivering
optimal care to patients with prostate cancer. This is especially true for patients who may …

The purpose of this study was to compare the diagnostic performance of 18F-DCFBC
PET/CT, a first-generation 18F-labeled prostate-specific membrane antigen (PSMA) …